FDA rejects Intarcia's drug pump
September 28, 2017 at 06:59 AM EDT
The FDA sent bad news to Intarcia Therapeutics, rejecting aspects of its manufacturing plan for a matchstick-sized drug pump for the treatment of Type 2 diabetes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|